title: Primary aortoenteric fistula following disseminated bacillus Calmette-Guérin infection: a case report.
abstract: The aim of this paper is to illustrate a rare case of primary aortoenteric fistula in the presence of disseminated infection and review the critical decision-making process. A clinical case was reviewed for its initial presentation, planning of treatment strategy and outcome. A secondary literature search for discussion on current accepted recommendations for primary aortoenteric fistula was then completed. Aortoenteric fistulas are rare pathologies with highly morbid potential. Their diagnosis requires a high index of suspicion and prompt intervention is critical to patient survival. In conclusion, aortoenteric fistula most commonly arises from large atherosclerotic aneurysms but can be caused by systemic infection. In the case of the latter, extra-anatomic repair appears to be the treatment of choice.
authors.affiliation: Department of Vascular Surgery, Loyola University Medical Center, Maywood, IL 60153, USA. mpittman@lumc.edu
authors.forename: M
authors.initials: M
authors.lastname: Pittman
authors.forename: L
authors.initials: L
authors.lastname: Sakai
authors.forename: R
authors.initials: R
authors.lastname: Craig
authors.forename: R
authors.initials: R
authors.lastname: Joehl
authors.forename: R
authors.initials: R
authors.lastname: Milner
mesh_terms: D000283:Administration, Intravesical; D000785:Aneurysm, Infected / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D001018:Aortic Diseases / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D001027:Aortography; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation; D002511:Cephalosporins; D003646:Debridement; D004378:Duodenal Diseases / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D004384:Duodenoscopy; D005402:Fistula / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D005773:Gastroscopy; D006801:Humans; D007412:Intestinal Fistula / Q000175:diagnosis / Q000382:microbiology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000472:pathogenicity*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000995:Antitubercular Agents; D001500:BCG Vaccine; D002511:Cephalosporins; C063437:MT 0703